Leukemia Clinical Trials

Showing 3461-3480 of 10,987 trials

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Community hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in newly diagnosed, otherwise untreated, advanced stage (stage III/IV) epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Stage III Ovarian CancerStage IV Ovarian CancerEpithelial Ovarian Cancer+4 more

Mercy Medical Center32 participantsStarted Apr 2014

Baltimore, Maryland, United States

COMPLETEDPhase 1/2

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

NCT02614066

The primary objectives of this study are to determine the safety and efficacy of brexucabtagene autoleucel (KTE-X19) in adult participants with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL).

Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Kite, A Gilead Company125 participantsStarted Mar 2016

La Jolla, California, United States • Los Angeles, California, United States • Orange, California, United States +30 more locations

HOT: HIPEC in Ovarian Cancer as Initial Treatment

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Related Searches

The Effect of an Auditory Rhythmic Cue on the Frequency of Rolling in Patients with Dysphagia and Parkinson's Disease

Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)

Study of High Efficient Killing Cell Therapy for Advanced NSCLC

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

A Phase 2 Clinical Study of ABSK061 and ABSK043

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant

Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation

Pediatric Cardiac Output Monitoring Observational Study

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NGAL in Prediction of AKI and Patient Outcomes

Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN

Improving Birth Outcomes in Bangladesh